12:57 21-10-2014
MAIN Russian
About us On-line subscription
KazakhstanTajikistanUzbekistanKyrgyzstanTurkmenistanWorld
POLITICSBUSINESSINCIDENTSSOCIETYCULTURESPORTANALYSISSCIENCE
Drug maker Shire rejects offer from AbbVie worth $46 billion

Bishkek (AKIpress) - drugs The Irish pharmaceutical company Shire said on Friday that it had rejected a takeover approach from the American drug maker AbbVie that valued the company at 27.2 billion pounds, or about $46.3 billion, the NY Times said. 

AbbVie, which is based in Chicago, revealed on Friday that it had first approached Shire in early May about a possible tie-up, but was rejected three times by Shire’s board of directors – the latest at the end of May. AbbVie was spun off from Abbott Laboratories last year.

Shire called AbbVie’s proposal “unsolicited and highly conditional” and said that it “fundamentally undervalued the company and its prospects.”

“We believe that Shire has a strong independent future,” Susan Kilsby, the Shire chairwoman, said in a statement.

Under British takeover rules, AbbVie has until July 18 to make a firm offer for Shire or walk away for at least six months before coming back with a further unsolicited offer. After three months, it is possible for the sides to reengage if Shire’s board agrees to it.

“There can be no certainty that any firm offer will be made,” AbbVie said in a statement. “Discussions are no longer ongoing.”

The latest cash and share offer was equal to £46.26 a share, AbbVie said.

Shire’s shares rose 13 percent to £42.26 in trading in London on Friday morning.


Twitterfacebookprint
16:29 20.06.2014
LATEST NEWS
12:57 30% of Kyrgyzstan’s schools lack central water supply12:45 Exact number of Kyrgyz citizens fighting on ISIS’ side remains unknown – expert12:41 New cars exempt from mandatory technical inspection in Kazakhstan - law12:32 Kyrgyz Transport Ministry asks ADB to consider possibility of funding of 3rd phase of construction of North-South alternative road12:28 Kyrgyz PMs propose abolishing of extension of pharmaceutical invention patents12:27 Cotton areas in Jalal-Abad region reduced by 790 ha in 2014 due to low cotton prices12:26 UNDP Administrator Helen Clark visits National Library of Uzbekistan12:21 All betting offices to be closed in Kyrgyzstan soon – Financial Market Supervision Chief12:16 Experts discuss role of Muslim women in society, their radicalization12:06 Daily power outages from 11.00 pm to 5.00 am planned for Osh to save electricity12:02 Kyrgyzstan, Iran discuss ways to expand bilateral trade12:01 Korean Deputy Minister of Trade, Energy visits Uzbekistan11:55 Civil council to monitor judicial system concerned about President’s initiatives to amend Constitution for further judicial reform11:43 Turkmenistan declares 2015 as Year of Neutrality, Peace11:40 Asian share gains fade as China data fail to temper growth anxiety11:33 Intensive movement of Kyrgyzstan towards Eurasian integration to remove all obstacles for migrant workers – Federal Council Chair11:21 Turkmenistan, Mexico discuss trade, economic cooperation in Ashgabat11:16 Mining investment in Kazakhstan to reach $30bn by 201711:04 Russian Federal Council Chairperson suggests signing of new agreement with Parliament of Kyrgyzstan11:02 Tajikistan, Luxembourg vow to develop cooperation in economy, culture, education spheres
Astana
+2° C
Ashgabat
+20° C
Bishkek
+11° C
Dushanbe
+22° C
Tashkent
+17° C
exchange rates
 
70.74
55.46
9.04
1.36
231.50
181.50
29.64
4.43
6.38
4.99
0.82
0.12
3084.28
2367.40
385.74
61.13
3.63
2.85
0.47
0.07

© AKIpress News Agency - 2001-2014
Use of the AKIpress.com materials must be accompanied by a hyperlink to www.akipress.com
Our address:
Moskovskaya str. 189, Bishkek, the Kyrgyz Republic
e-mail: english@akipress.org, akipressenglish@gmail.com;
Tel/Fax: +996(312)90-07-75